Dermatology · Chicago, IL
NPI
1598931719
Since 2008
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
676 N Saint Clair St, Suite 1600
Chicago, IL, 60611
Phone (312) 695-8106
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,226 services
Medicare patients, 2024
479
Average age 74
Drug cost, 2024
$370K
2,057 prescriptions
Company payments, 2025
$116
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria Colavincenzo was code 99214 (office e&m - established), 384 times for 317 patients. In total Maria Colavincenzo billed 1,226 services in 30 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 384 | 317 | $101.74 | $39K |
| 17003 Destruction Skin Lesion | Office | 230 | 53 | $5.46 | $1,255 |
| 99213 Office E&M - Established | Office | 113 | 107 | $72.07 | $8,144 |
| 17000 Destruction Skin Lesion | Office | 93 | 82 | $43.34 | $4,030 |
| 17110 Destruction Skin Lesion | Office | 67 | 60 | $93.87 | $6,289 |
| 11102 Skin Biopsy | Office | 57 | 56 | $75.56 | $4,307 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 51 | 20 | $0.72 | $36.55 |
| 99215 Office E&M - Established | Office | 39 | 36 | $148.86 | $5,806 |
| 11103 Skin Biopsy | Office | 27 | 22 | $42.82 | $1,156 |
| 11900 Skin | Office | 25 | 20 | $40.51 | $1,013 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 25 | 25 | $13.70 | $343 |
| 99204 Office E&M - New | Office | 20 | 20 | $144.94 | $2,899 |
| 99203 Office E&M - New | Office | 20 | 20 | $87.33 | $1,747 |
| 11104 Skin Biopsy | Office | 12 | 12 | $103.09 | $1,237 |
By year: 2022 $79K for 1,265 services; 2023 $90K for 1,427 services; 2024 $81K for 1,226 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria Colavincenzo prescribed most often to Medicare patients was Minoxidil, with 650 prescriptions and refills. In total Maria Colavincenzo wrote 2,057 Medicare prescriptions that cost $370K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Minoxidil Generic | 650 | 1,478 | 153 | $9,016 |
| Dutasteride Generic | 233 | 560 | 66 | $5,658 |
| Ketoconazole Generic | 147 | 176 | 83 | $2,506 |
| Clobetasol Propionate Generic | 123 | 131 | 64 | $4,976 |
| Triamcinolone Acetonide Generic | 114 | 139 | 78 | $973 |
| Finasteride Generic | 88 | 212 | 25 | $1,216 |
| Hydroxychloroquine Sulfate Generic | 68 | 115 | 17 | $1,721 |
| Spironolactone Generic | 65 | 136 | 16 | $1,311 |
| Fluocinonide Generic | 58 | 65 | 33 | $1,586 |
| Tretinoin Generic | 56 | 67 | 24 | $4,331 |
| Betamethasone Dipropionate Generic | 42 | 44 | 24 | $1,329 |
| Clindamycin Phosphate Generic | 39 | 44 | 18 | $1,791 |
| Mupirocin Generic | 27 | 27 | 17 | $148 |
| Doxycycline Monohydrate Generic | 26 | 37 | 11 | $1,005 |
| Olumiant Baricitinib | 26 | 36 | Under 11 | $134K |
Brand drugs: 131 claims; generic drugs: 1,926 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria Colavincenzo $116 ($116 in general payments such as food, travel and fees) from 3 companies. The largest payer was Pfizer Inc. with $116.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $116 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.